[go: up one dir, main page]

ES2103161B1 - DERIVATIVES OF CYCLLOHEPTIMIDAZOLE, METHOD OF MANUFACTURE OF THE SAME AND THERAPEUTIC AGENTS THAT CONTAIN THESE COMPOUNDS. - Google Patents

DERIVATIVES OF CYCLLOHEPTIMIDAZOLE, METHOD OF MANUFACTURE OF THE SAME AND THERAPEUTIC AGENTS THAT CONTAIN THESE COMPOUNDS.

Info

Publication number
ES2103161B1
ES2103161B1 ES09301036A ES9301036A ES2103161B1 ES 2103161 B1 ES2103161 B1 ES 2103161B1 ES 09301036 A ES09301036 A ES 09301036A ES 9301036 A ES9301036 A ES 9301036A ES 2103161 B1 ES2103161 B1 ES 2103161B1
Authority
ES
Spain
Prior art keywords
derivatives
cyclloheptimidazole
compounds
manufacture
contain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES09301036A
Other languages
Spanish (es)
Other versions
ES2103161A1 (en
Inventor
Tsuyoshi Tomiyama
Akira Tomiyama
Takashi Yanagisawa
Naoto Ueyama
Tomoyuki Kawai
Motoharu Sonegawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kotobuki Seiyaku Co Ltd
Original Assignee
Kotobuki Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kotobuki Seiyaku Co Ltd filed Critical Kotobuki Seiyaku Co Ltd
Publication of ES2103161A1 publication Critical patent/ES2103161A1/en
Application granted granted Critical
Publication of ES2103161B1 publication Critical patent/ES2103161B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

DERIVADOS DE CICLOHEPTIMIDAZOL, METODO DE FABRICACION DE LOS MISMOS Y AGENTES TERAPEUTICOS QUE CONTIENEN ESTOS COMPUESTOS; LOS DERIVADOS DE CICLOHEPTIMIDAZOL ESTAN REPRESENTADOS POR LA FORMULA SIGUIENTE FORMULA (EN LA QUE R1 REPRESENTA H O GRUPO ISOPROPILO; R2 REPRESENTA ALQUILO INFERIOR; R3 REPRESENTA UN GRUPO DE ACIDO CARBOXILICO O TETRAZOL; A Y A1 SON GRUPOS SUSTITUIDOS EN LAS POSICIONES 4 U 8 Y A1 ES HIDROGENO O UN GRUPO HIDROXI CUANDO A ES HIDROGENO O A Y A1 ES UN GRUPO OXO; Y LA LINEA DE TRAZOS "----" REPRESENTA DOS DOBLES ENLACES O ENLACES SENCILLOS SATURADOS. SE PREPARAN HACIENDO REACCIONAR UN CICLOHEPTIMIDEZOL CON UN BIFENILO. SON UTILES COMO AGENTES ANTIHIPERTENSIVOS O AGENTES CONTRA EL FALLO CARDIACO CONGESTIVO.DERIVATIVES OF CYCLLOHEPTIMIDAZOLE, METHOD OF MANUFACTURE OF THE SAME AND THERAPEUTIC AGENTS THAT CONTAIN THESE COMPOUNDS; THE CYCLOHEPTIMIDAZOLE DERIVATIVES ARE REPRESENTED BY THE FORMULA BELOW FORMULA (IN WHICH R1 REPRESENTS THE ISOPROPYL GROUP; R2 REPRESENTS A GROUP OF LOWER ALKYL; HYDROGEN OR A HYDROXY GROUP WHEN A IS HYDROGEN OAY A1 IS AN OXO GROUP; AND THE LINE OF TRACES "----" REPRESENTS TWO DOUBLE LINKS OR SATURATED LINKS. ANTI-HYPERTENSIVES OR AGENTS AGAINST CONGESTIVE CARDIAC FAILURE.

ES09301036A 1992-05-22 1993-05-14 DERIVATIVES OF CYCLLOHEPTIMIDAZOLE, METHOD OF MANUFACTURE OF THE SAME AND THERAPEUTIC AGENTS THAT CONTAIN THESE COMPOUNDS. Expired - Fee Related ES2103161B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4131142A JP2707390B2 (en) 1992-05-22 1992-05-22 Cycloheptoimidazole derivative, method for producing the same, and drug containing the same

Publications (2)

Publication Number Publication Date
ES2103161A1 ES2103161A1 (en) 1997-08-16
ES2103161B1 true ES2103161B1 (en) 1998-04-01

Family

ID=15050986

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09301036A Expired - Fee Related ES2103161B1 (en) 1992-05-22 1993-05-14 DERIVATIVES OF CYCLLOHEPTIMIDAZOLE, METHOD OF MANUFACTURE OF THE SAME AND THERAPEUTIC AGENTS THAT CONTAIN THESE COMPOUNDS.

Country Status (10)

Country Link
US (1) US5409947A (en)
JP (1) JP2707390B2 (en)
KR (1) KR0152299B1 (en)
BE (1) BE1006419A3 (en)
DE (1) DE4316117C2 (en)
ES (1) ES2103161B1 (en)
FR (1) FR2691461B1 (en)
GB (1) GB2267089B (en)
IT (1) IT1265077B1 (en)
ZA (1) ZA933151B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA945190B (en) * 1993-07-30 1995-02-24 Kotobuki Seiyaku Co Ltd Carboxymethylidenecycloheptimidazole derivatives method or manufacturing the same and therapeutic agents containing these compounds
JP4316686B2 (en) * 1994-09-05 2009-08-19 壽製薬株式会社 Cycloheptimidazole derivative
US6162922A (en) * 1998-01-30 2000-12-19 Bristol-Myers Squibb Co. Method for preparing N-substituted heterocyclic derivatives using a phase-transfer catalyst
US6638937B2 (en) 1998-07-06 2003-10-28 Bristol-Myers Squibb Co. Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
JP4018816B2 (en) * 1998-09-08 2007-12-05 壽製薬株式会社 Cycloheptenone derivative and method for producing the same, and method for producing cycloheptimidazole derivative using the same
JP2004501863A (en) * 2000-01-19 2004-01-22 アルテオン　インコーポレーテッド Thiazole, imidazole and oxazole compounds and treatment of protein aging related diseases
PL1673107T3 (en) * 2003-10-10 2008-06-30 Abbott Laboratories Gmbh Pharmaceutical composition comprising a selective i1 imidazoline receptor agonist and an angiotensin ii receptor blocker
JP4675586B2 (en) * 2004-06-23 2011-04-27 壽製薬株式会社 Drugs for the treatment of multiple episodes of hypertension and serum hyperuricemia
CN101119747A (en) * 2004-07-02 2008-02-06 三共株式会社 tissue factor production inhibitor
KR101021828B1 (en) 2004-10-27 2011-03-17 다이이찌 산쿄 가부시키가이샤 Benzene Compounds Having Two or More Substituents
WO2025202469A1 (en) * 2024-03-28 2025-10-02 Junia Use of a derivative of hinokitiol for its fungicidal and/or bactericidal activity on fungi, oomycetes and/or pathogenic bacteria of plants and crop seeds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250554A (en) * 1989-10-24 1993-10-05 Takeda Chemical Industries, Ltd. Benzimidazole derivatives useful as angiotensin II inhibitors
US5104891A (en) * 1989-12-11 1992-04-14 G. D. Searle & Co. Cycloheptimidazolone compounds as angiotensin ii antagonists for control of hypertension

Also Published As

Publication number Publication date
DE4316117A1 (en) 1993-11-25
FR2691461A1 (en) 1993-11-26
GB2267089A (en) 1993-11-24
ITMI931019A1 (en) 1994-11-18
BE1006419A3 (en) 1994-08-23
FR2691461B1 (en) 1994-11-10
GB2267089B (en) 1995-10-04
ITMI931019A0 (en) 1993-05-18
IT1265077B1 (en) 1996-10-30
DE4316117C2 (en) 2002-06-27
JPH05320139A (en) 1993-12-03
KR0152299B1 (en) 1998-10-15
GB9310492D0 (en) 1993-07-07
ZA933151B (en) 1993-12-06
JP2707390B2 (en) 1998-01-28
ES2103161A1 (en) 1997-08-16
KR940005615A (en) 1994-03-21
US5409947A (en) 1995-04-25

Similar Documents

Publication Publication Date Title
ES2064700T3 (en) DERIVATIVES OF ADENOSINE WITH PHARMACEUTICAL ACTIVITY AS ANTI-HYPERTENSIVES.
ES2168357T3 (en) EP2 RECEIVER AGONISTS AS AGENTS TO DECREASE INTRAOCULAR PRESSURE.
ES2103161B1 (en) DERIVATIVES OF CYCLLOHEPTIMIDAZOLE, METHOD OF MANUFACTURE OF THE SAME AND THERAPEUTIC AGENTS THAT CONTAIN THESE COMPOUNDS.
ES2189330T3 (en) HETEROCICLIC DERIVATIVES N6 OF THE SUBSTITUTED ADENOSINE.
ES2152936T3 (en) BENZOHETEROCICLIC COMPOUNDS.
ES2094719T3 (en) DERIVATIVES OF PIRAZOLE AND HERBICIDES THAT CONTAIN THEM.
ES2058069T3 (en) DERIVATIVES OF 5H-1,3,4-TIADIAZOLO- (3,2-A) -PIRIMIDIN-5-ONA AND NEW AGRICULTURAL-HORTICOLA FUNGICIDE COMPOUND CONTAINING SUCH DERIVATIVE.
DK0513351T3 (en) 2-Nitroimidazole derivative, its preparation and radiation sensitizer containing same as active ingredient
ES2123873T3 (en) PYROLLOCARBAZOLE.
ES2040879T3 (en) PROCEDURE FOR THE PREPARATION OF PIRIMIDINYLAMINIC PIPERIDINE DERIVATIVES.
ES2110260T3 (en) ANDROSTENONAS.
ES2101073T3 (en) NEW AZA-ANDROSTANO-DERIVATIVES 17-BETA-SUBSTITUTED.
AR241180A1 (en) Herbicidally active substituted benzisoxazole (or benzisothiazone) compounds
ES2003190A6 (en) Silicate- and magnesium-free peroxide stabilizers.
YU46561B (en) PROCEDURE FOR STABILIZATION OF AQUEOUS RANITIDINE SOLUTION
ES2167510T3 (en) AGENTS TO IMPROVE THE DREAM.
ES2028042T3 (en) PROCEDURE FOR THE OBTAINING OF 1,8-NAPHTIRIDINE DERIVATIVES AND FUNGIDS CONTAINING THEM.
ES2010513B3 (en) NEW DERIVATIVES OF 6- OR 7-METHYLENE ANROSTA-1,4-DIENO3,17-DIONA AND PROCEDURE FOR ITS PREPARATION.
MX9306588A (en) ANTIRRETROVIRAL ACYL COMPOUND.
ES8603496A1 (en) A PROCEDURE FOR THE PREPARATION OF NEW CEPHALOSPORIN DERIVATIVES
ES2160726T3 (en) DERIVATIVES OF PIPERAZIN-2,5-DIONA AS MODULATORS OF RESISTANCE TO MULTIPLE DRUGS.
ATE122669T1 (en) ZEARALANOL DERIVATIVES WITH ANABOLYTIC ACTION.
ES2056194T3 (en) ANTIDEPRESSIVE TETRACICLIC COMPOUNDS.
FI940003A0 (en) The amino acid derivatives
ES2061556T3 (en) AMIDA DERIVATIVES AND THEIR PRODUCTION AND AGRICULTURAL FUNGICIDES THAT CONTAIN THEM.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19970816

Kind code of ref document: A1

Effective date: 19970816

FD2A Announcement of lapse in spain

Effective date: 20180806